Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR). Meeting Abstract

cited authors

  • Bonomi, Marcelo Raul; Blakaj, Dukagjin; Sher, David; Kabarriti, Rafi; Colvett, Kyle; Reiner, Seth; Takiar, Vinita; Biagioli, Matthew; Bar-Ad, Voichita C.; Goyal, Sharad; Muzyka, Brian C.; Niermann, Kenneth J.; Reid, Tony R.; Oronsky, Bryan; Abrouk, Nacer; Caroen, Scott; Cabrales, Pedro; Sonis, Stephen T.

Publication Date

  • June 1, 2022

webpage

published in

category

volume

  • 40

issue

  • 16